SCHEMBL467320

SCHEMBL467320

Fc1ccc(CCl)cc1.[MgH2]

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 3/20 0.50
LOXL2 Q9Y4K0 1/20 0.50
TAAR1 Q96RJ0 3/20 0.46
AGXT P21549 2/20 0.44
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
PLA2G1B P04054 1/20 0.39
ATG4B Q9Y4P1 1/20 0.39
MAOB P27338 1/20 0.39
MIF P14174 1/20 0.39
LMNA P02545 1/20 0.39
CYP19A1 P11511 1/20 0.39
CYP11B1 P15538 1/20 0.39
CYP11B2 P19099 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL186435 0.97
SCHEMBL852177 0.94 IDO1 (0.50) IDO1LOXL2TAAR1AGXTCA1
Phosphine SCHEMBL5512746 0.94 IDO1 (0.50) IDO1LOXL2TAAR1AGXTCA1
Magnesium SCHEMBL29786468 0.94 IDO1 (0.50) IDO1LOXL2TAAR1AGXTCA1
Hydrochloric Acid SCHEMBL28502839 0.94 IDO1 (0.50) IDO1LOXL2TAAR1AGXTCA1
SCHEMBL1725688 0.89 MAOB (0.52) IDO1LOXL2TAAR1AGXTCA1
SCHEMBL27864115 0.89 IDO1 (0.46) IDO1LOXL2TAAR1AGXTCA1
SCHEMBL2990337 0.89 TAAR1 (0.54) IDO1LOXL2TAAR1AGXTMAOB
SCHEMBL10564566 0.89 IDO1 (0.46) IDO1LOXL2TAAR1AGXTCA1
(Chloromethyl)Benzene SCHEMBL11209021 0.87 PLA2G1B (0.48) IDO1LOXL2TAAR1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025067168-A1 AZA FUSED RING COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF 苏州爱科百发生物医药技术有限公司 2025-04-03 WO disclosed
CN-112262139-B Aminopyrrolotriazines as kinase inhibitors 百时美施贵宝公司 2023-07-25 CN disclosed
CN-111566103-B Aminoimidazopyrazines as kinase inhibitors 百时美施贵宝公司 2023-06-23 CN disclosed
CN-109743875-B Inhibitors of the MENIN-MLL interaction 生命医药有限责任公司 2022-04-29 CN disclosed
CN-111943886-B Substituted pyridine compound and preparation method thereof 华中师范大学 2022-02-08 CN disclosed
CN-110177786-B Substituted pyrazolo [1,5-A ] pyridine compounds as RET kinase inhibitors 阿雷生物药品公司 2021-12-14 CN disclosed
CN-111961045-A Synthesis method of 1, 6-naphthyridine-4 (1H) -ketone compound 南京纳丁菲医药科技有限公司 2020-11-20 CN disclosed
CN-111943886-A Substituted pyridine compound and preparation method thereof 华中师范大学 2020-11-17 CN disclosed
EP-3087060-A1 PYRIMIDONE CARBOXAMIDE COMPOUNDS AS PDE2 INHIBITORS Merck Sharp & Dohme Corp. (US) 2016-11-02 EP disclosed
WO-2015096651-A1 PYRIMIDONE CARBOXAMIDE COMPOUNDS AS PDE2 INHIBITORS MERCK SHARP & DOHME CORP. (US) 2015-07-02 WO disclosed
WO-2000024719-A1 PROSTAGLANDIN ENDOPEROXIDE H SYNTHASE BIOSYNTHESIS INHIBITORS ABBOTT LABORATORIES (US) 2000-05-04 WO disclosed
WO-1999010331-A1 ARYLPYRIDAZINONES AS PROSTAGLANDIN ENDOPEROXIDE H SYNTHASE BIOSYNTHESIS INHIBITORS ABBOTT LABORATORIES (US) 1999-03-04 WO disclosed
US-5382683-A 2-aminopropanamide derivatives FISONS CORPORATION (US) 1995-01-17 US disclosed
EP-0326240-B1 2-Amino acetamide derivatives FISONS CORP (US) 1993-10-20 EP disclosed
US-5093524-A 2-(alkylamino)acetamide derivatives FISONS CORPORATION (US) 1992-03-03 US disclosed
EP-0279937-B1 2-AMINOACETAMIDE DERIVATIVES FISONS CORPORATION (US) 1991-10-09 EP disclosed
EP-0401253-A1 2-AMINO ACETAMIDE DERIVATIVES FISONS CORPORATION (US) 1990-12-12 EP disclosed
US-4871872-A 2-[(2-aminoacetyl)amino]acetamide derivatives FISONS CORPORATION (US) 1989-10-03 US disclosed
EP-0326240-A1 2-Amino acetamide derivatives FISONS CORPORATION (US) 1989-08-02 EP disclosed
WO-1989006646-A1 2-AMINO ACETAMIDE DERIVATIVES FISONS CORPORATION (US) 1989-07-27 WO disclosed